Silvercrest Asset Management Group LLC Cooper Companies, Inc. Transaction History

Silvercrest Asset Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$306.88 - $380.0 $425,028 - $526,300	-1,385 Reduced 21.52%	5,051 $1.91 Million
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $148,166 - $186,361	469 Added 7.86%	6,436 $2.05 Million
Q2 2023 Aug 14, 2023	SELL	$346.15 - $392.09 $93,460 - $105,864	-270 Reduced 4.33%	5,967 $2.29 Million
Q1 2023 May 15, 2023	BUY	$323.56 - $373.36 $16,501 - $19,041	51 Added 0.82%	6,237 $2.33 Million
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $786,543 - $1.06 Million	3,163 Added 104.63%	6,186 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $529,994 - $677,575	2,009 Added 198.13%	3,023 $798,000
Q2 2022 Aug 15, 2022	BUY	$301.4 - $428.42 $305,619 - $434,417	1,014 New	1,014 $318,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.